Molecular epidemiology of human herpesvirus 8 variants in Kaposi's sarcoma from Iranian patients

Virus Research

Volumn 163, Issue 2, 2012, Pages 644-649

  Jalilvand, Somayeh ^a   Tornesello, Maria Lina ^b   Buonaguro, Franco M ^b   Buonaguro, Luigi ^b   Naraghi, Zahra Safaie ^c   Shoja, Zabihollah ^a   Ziaee, Abed Ali ^d   Hamkar, Rasool ^a   Shahmahmoodi, Shohreh ^a   Nategh, Rakhshandeh ^a   Mokhtari Azad, Talat ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Human herpesvirus 8; Iran; Kaposi's sarcoma; ORF K1; ORF T0.7; ORF26

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IRAN; KAPOSI SARCOMA; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEQUENCE ANALYSIS; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; GENOTYPE; HERPESVIRUS 8, HUMAN; HUMANS; IRAN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; SARCOMA, KAPOSI; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SKIN;

HUMAN HERPESVIRUS 8;

EID: 84856520183     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.09.027     Document Type: Article

References (33)

1. Biggar R.J., Horm J., Goedert J.J., Melbye M. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am. J. Epidemiol. 1987, 126:578-586.
2. Buonaguro F.M., Tomesello M.L., Buonaguro L., Satriano R.A., Ruocco E., Castello G., Ruocco V. Kaposi's sarcoma: aetiopathogenesis, histology and clinical features. J. Eur. Acad. Dermatol. Venereol. 2003, 17:138-154.
3. Buonaguro F.M., Tornesello M.L., Beth-Giraldo E., Hatzakis A., Mueller N., Downing R., Biryamwaho B., Sempala S.D., Giraldo G. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int. J. Cancer 1996, 65:25-28.
4. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
5. Cook P.M., Whitby D., Calabro M.L., Luppi M., Kakoola D.N., Hjalgrim H., Ariyoshi K., Ensoli B., Davison A.J., Schulz T.F. Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group. AIDS 1999, 13:1165-1176.
6. Davidovici B., Karakis I., Bourboulia D., Ariad S., Zong J., Benharroch D., Dupin N., Weiss R., Hayward G., Sarov B., Boshoff C. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J. Natl. Cancer Inst. 2001, 93:194-202.
7. de Souza V., Sumita L.M., Nascimento M.C., Oliveira J., Mascheretti M., Quiroga M., Freire W.S., Tateno A., Boulos M., Mayaud P., Pannuti C.S. Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J. Infect. Dis. 2007, 196:844-852.
8. Duprez R., Hbid O., Afonso P., Quach H., Belloul L., Fajali N., Ismaili N., Benomar H., Hassane T.E., Huerre M., Quintana-Murci L., Gessain A. Molecular epidemiology of the HHV-8 K1 gene from Moroccan patients with Kaposi's sarcoma. Virology 2006, 353:121-132.
9. Foster C.B., Lehrnbecher T., Samuels S., Stein S., Mol F., Metcalf J.A., Wyvill K., Steinberg S.M., Kovacs J., Blauvelt A., Yarchoan R., Chanock S.J. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000, 96:2562-2567.
10. Fredricks D.N., Relman D.A. Paraffin removal from tissue sections for digestion and PCR analysis. Biotechniques 1999, 26:198-200.
11. Gao S.J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., Newton R., Rinaldo C.R., Saah A., Phair J., Detels R., Chang Y., Moore P.S. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 1996, 2:925-928.
12. Gaya A., Esteve A., Casabona J., McCarthy J.J., Martorell J., Schulz T.F., Whitby D. Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients. AIDS 2004, 18:199-204.
13. Gazouli M., Zavos G., Papaconstantinou I., Lukas J.C., Zografidis A., Boletis J., Kostakis A. The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. Anticancer Res. 2004, 24:1311-1314.
14. Hayward G.S. KSHV strains: the origins and global spread of the virus. Semin. Cancer Biol. 1999, 9:187-199.
15. IARC Cancer Incidence in Five Continents 2007, vol. IXIARC. Scientific Publications, Lyonn.
16. Iscovich J., Boffetta P., Franceschi S., Azizi E., Sarid R. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 2000, 88:500-517.
17. Jalilvand S., Shoja Z., Mokhtari-Azad T., Nategh R., Gharehbaghian A. Seroprevalence of human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect. Agent Cancer 2011, 6:5.
18. Kaposi M. Idiopathisches multiples pigment sarcoma de Haut. Arch Dermatol. Syphil. 1872, 4:265-267.
19. Mancuso R., Biffi R., Valli M., Bellinvia M., Tourlaki A., Ferrucci S., Brambilla L., Delbue S., Ferrante P., Tinelli C., Clerici M. HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma. J. Med. Virol. 2008, 80:2153-2160.
20. Mohanna S., Maco V., Bravo F., Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int. J. Infect. Dis. 2005, 9:239-250.
21. Mousavi S.M., Mohagheghi M.A., Jerrahi A.M. Epidemiology of Kaposi's sarcoma in Iran: 1984-2006. Asian Pac. J. Cancer Prev. 2007, 8:557-560.
22. Penn I. Kaposi's sarcoma in immunosuppressed patients. J. Clin. Lab. Immunol. 1983, 12:1-10.
23. Poole L.J., Zong J.C., Ciufo D.M., Alcendor D.J., Cannon J.S., Ambinder R., Orenstein J.M., Reitz M.S., Hayward G.S. Comparison of genetic variability at multiple loci across the genomes of the major subgroups of Kaposi's sarcoma associated herpesvirus (HHV8) reveals evidence for recombination and for two distinct types of ORF-K15 alleles at the right hand end.J. Virol. 1999, 73:6646-6660.
24. Rezza G., Andreoni M., Dorrucci M., Pezzotti P., Monini P., Zerboni R., Salassa B., Colangeli V., Sarmati L., Nicastri E., Barbanera M., Pristera R., Aiuti F., Ortona L., Ensoli B. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J. Natl. Cancer Inst. 1999, 91:1468-1474.
25. Serwadda D., Carswell W., Ayuko W.O., Wamukota W., Madda P., Downing R.G. Further experience with Kaposi's sarcoma in Uganda. Br. J. Cancer 1986, 53:497-500.
26. Tornesello M.L., Biryahwaho B., Downing R., Hatzakis A., Alessi E., Cusini M., Ruocco V., Katongole-Mbidde E., Loquercio G., Buonaguro L., Buonaguro F.M. Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era. Virology 2010, 398:280-289.
27. Tornesello M.L., Buonaguro L., Cristillo M., Biryahwaho B., Downing R., Hatzakis A., Alessi E., Cusini M., Ruocco V., Viviano E., Romano N., Katongole-Mbidde E., Buonaguro F.M. MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients. Biomarkers 2011, 16:42-50.
28. van der Kuyl A.C., Polstra A.M., Weverling G.J., Zorgdrager F., van den B.R., Cornelissen M. An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi's sarcoma: a case-control study. AIDS 2004, 18:1206-1208.
29. Whitby D., Marshall V.A., Bagni R.K., Miley W.J., McCloud T.G., Hines-Boykin R., Goedert J.J., Conde B.A., Nagashima K., Mikovits J., Dittmer D.P., Newman D.J. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Int. J. Cancer 2007, 120:321-328.
30. Whitby D., Marshall V.A., Bagni R.K., Wang C.D., Gamache C.J., Guzman J.R., Kron M., Ebbesen P., Biggar R.J. Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J. Gen. Virol. 2004, 85:155-163.
31. Zong J., Ciufo D.M., Viscidi R., Alagiozoglou L., Tyring S., Rady P., Orenstein J., Boto W., Kalumbuja H., Romano N., Melbye M., Kang G.H., Boshoff C., Hayward G.S. Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J. Clin. Virol. 2002, 23:119-148.
32. Zong J.C., Ciufo D.M., Alcendor D.J., Wan X., Nicholas J., Browning P.J., Rady P.L., Tyring S.K., Orenstein J.M., Rabkin C.S., Su I.J., Powell K.F., Croxson M., Foreman K.E., Nickoloff B.J., Alkan S., Hayward G.S. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 1999, 73:4156-4170.
33. Zong J.C., Kajumbula H., Boto W., Hayward G.S. Evaluation of global clustering patterns and strain variation over an extended ORF26 gene locus from Kaposi's sarcoma herpesvirus. J. Clin. Virol. 2007, 40:19-25.